Read + Share
Amedeo Smart
Independent Medical Education
Kikuchi H, Goda A, Takeuchi K, Inami T, et al. Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension. Am J Cardiol 2023;206:31-34.PMID: 37677880
Email
LinkedIn
Facebook
Twitter
Privacy Policy